Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 5,148
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,809 million
Market Forecast in 2031(Value)
US$ 5,148 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Crude Heparin market competitiveness, regional economic performance, and supply chain configurations.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
The global Crude Heparin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Crude Heparin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Bovine Heparin and Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., LMWH in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Pig Intestine Mucosa Heparin dominance in Europe vs. Bovine Heparin and Others demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Crude Heparin Product Scope
1.2 Crude Heparin by Type
1.2.1 Global Crude Heparin Sales by Type (2020 & 2024 & 2031)
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Crude Heparin by Application
1.3.1 Global Crude Heparin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Crude Heparin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Crude Heparin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Crude Heparin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Crude Heparin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Crude Heparin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Crude Heparin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Crude Heparin Sales Market Share by Region (2020-2025)
2.2.2 Global Crude Heparin Revenue Market Share by Region (2020-2025)
2.3 Global Crude Heparin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Crude Heparin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Crude Heparin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Crude Heparin Market Size and Prospective (2020-2031)
2.4.2 Europe Crude Heparin Market Size and Prospective (2020-2031)
2.4.3 China Crude Heparin Market Size and Prospective (2020-2031)
2.4.4 Japan Crude Heparin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Crude Heparin Historic Market Review by Type (2020-2025)
3.1.1 Global Crude Heparin Sales by Type (2020-2025)
3.1.2 Global Crude Heparin Revenue by Type (2020-2025)
3.1.3 Global Crude Heparin Price by Type (2020-2025)
3.2 Global Crude Heparin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Crude Heparin Sales Forecast by Type (2026-2031)
3.2.2 Global Crude Heparin Revenue Forecast by Type (2026-2031)
3.2.3 Global Crude Heparin Price Forecast by Type (2026-2031)
3.3 Different Types Crude Heparin Representative Players
4 Global Market Size by Application
4.1 Global Crude Heparin Historic Market Review by Application (2020-2025)
4.1.1 Global Crude Heparin Sales by Application (2020-2025)
4.1.2 Global Crude Heparin Revenue by Application (2020-2025)
4.1.3 Global Crude Heparin Price by Application (2020-2025)
4.2 Global Crude Heparin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Crude Heparin Sales Forecast by Application (2026-2031)
4.2.2 Global Crude Heparin Revenue Forecast by Application (2026-2031)
4.2.3 Global Crude Heparin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Crude Heparin Application
5 Competition Landscape by Players
5.1 Global Crude Heparin Sales by Players (2020-2025)
5.2 Global Top Crude Heparin Players by Revenue (2020-2025)
5.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2024)
5.4 Global Crude Heparin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Crude Heparin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Crude Heparin, Product Type & Application
5.7 Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Crude Heparin Sales by Company
6.1.1.1 North America Crude Heparin Sales by Company (2020-2025)
6.1.1.2 North America Crude Heparin Revenue by Company (2020-2025)
6.1.2 North America Crude Heparin Sales Breakdown by Type (2020-2025)
6.1.3 North America Crude Heparin Sales Breakdown by Application (2020-2025)
6.1.4 North America Crude Heparin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Crude Heparin Sales by Company
6.2.1.1 Europe Crude Heparin Sales by Company (2020-2025)
6.2.1.2 Europe Crude Heparin Revenue by Company (2020-2025)
6.2.2 Europe Crude Heparin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Crude Heparin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Crude Heparin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Crude Heparin Sales by Company
6.3.1.1 China Crude Heparin Sales by Company (2020-2025)
6.3.1.2 China Crude Heparin Revenue by Company (2020-2025)
6.3.2 China Crude Heparin Sales Breakdown by Type (2020-2025)
6.3.3 China Crude Heparin Sales Breakdown by Application (2020-2025)
6.3.4 China Crude Heparin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Crude Heparin Sales by Company
6.4.1.1 Japan Crude Heparin Sales by Company (2020-2025)
6.4.1.2 Japan Crude Heparin Revenue by Company (2020-2025)
6.4.2 Japan Crude Heparin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Crude Heparin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Crude Heparin Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Bioiberica
7.1.1 Bioiberica Company Information
7.1.2 Bioiberica Business Overview
7.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Bioiberica Crude Heparin Products Offered
7.1.5 Bioiberica Recent Development
7.2 Shenzhen Hepalink
7.2.1 Shenzhen Hepalink Company Information
7.2.2 Shenzhen Hepalink Business Overview
7.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Shenzhen Hepalink Crude Heparin Products Offered
7.2.5 Shenzhen Hepalink Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi Crude Heparin Products Offered
7.3.5 Sanofi Recent Development
7.4 Nanjing King-friend
7.4.1 Nanjing King-friend Company Information
7.4.2 Nanjing King-friend Business Overview
7.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Nanjing King-friend Crude Heparin Products Offered
7.4.5 Nanjing King-friend Recent Development
7.5 Fengrun Biological Technology
7.5.1 Fengrun Biological Technology Company Information
7.5.2 Fengrun Biological Technology Business Overview
7.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Fengrun Biological Technology Crude Heparin Products Offered
7.5.5 Fengrun Biological Technology Recent Development
7.6 Aspen Oss
7.6.1 Aspen Oss Company Information
7.6.2 Aspen Oss Business Overview
7.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Aspen Oss Crude Heparin Products Offered
7.6.5 Aspen Oss Recent Development
7.7 Hebei Changshan Biochemical
7.7.1 Hebei Changshan Biochemical Company Information
7.7.2 Hebei Changshan Biochemical Business Overview
7.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Crude Heparin Products Offered
7.7.5 Hebei Changshan Biochemical Recent Development
7.8 Changzhou Qianhong
7.8.1 Changzhou Qianhong Company Information
7.8.2 Changzhou Qianhong Business Overview
7.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Changzhou Qianhong Crude Heparin Products Offered
7.8.5 Changzhou Qianhong Recent Development
7.9 Hepac (Darling Ingredients)
7.9.1 Hepac (Darling Ingredients) Company Information
7.9.2 Hepac (Darling Ingredients) Business Overview
7.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Hepac (Darling Ingredients) Crude Heparin Products Offered
7.9.5 Hepac (Darling Ingredients) Recent Development
7.10 Huaian MDC Pharmaceutical
7.10.1 Huaian MDC Pharmaceutical Company Information
7.10.2 Huaian MDC Pharmaceutical Business Overview
7.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Huaian MDC Pharmaceutical Crude Heparin Products Offered
7.10.5 Huaian MDC Pharmaceutical Recent Development
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Company Information
7.11.2 Yantai Dongcheng Biochemicals Business Overview
7.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Yantai Dongcheng Biochemicals Crude Heparin Products Offered
7.11.5 Yantai Dongcheng Biochemicals Recent Development
8 Crude Heparin Manufacturing Cost Analysis
8.1 Crude Heparin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Crude Heparin
8.4 Crude Heparin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Crude Heparin Distributors List
9.3 Crude Heparin Customers
10 Crude Heparin Market Dynamics
10.1 Crude Heparin Industry Trends
10.2 Crude Heparin Market Drivers
10.3 Crude Heparin Market Challenges
10.4 Crude Heparin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Crude Heparin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Crude Heparin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Crude Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Crude Heparin Sales (Tons) by Region (2020-2025)
Table 5. Global Crude Heparin Sales Market Share by Region (2020-2025)
Table 6. Global Crude Heparin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Crude Heparin Revenue Share by Region (2020-2025)
Table 8. Global Crude Heparin Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Crude Heparin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Crude Heparin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Crude Heparin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Crude Heparin Sales by Type (Tons) & (2020-2025)
Table 13. Global Crude Heparin Sales Share by Type (2020-2025)
Table 14. Global Crude Heparin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Crude Heparin Price by Type (US$/Kg) & (2020-2025)
Table 16. Global Crude Heparin Sales by Type (Tons) & (2026-2031)
Table 17. Global Crude Heparin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Crude Heparin Price by Type (US$/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Crude Heparin Sales by Application (Tons) & (2020-2025)
Table 21. Global Crude Heparin Sales Share by Application (2020-2025)
Table 22. Global Crude Heparin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Crude Heparin Price by Application (US$/Kg) & (2020-2025)
Table 24. Global Crude Heparin Sales by Application (Tons) & (2026-2031)
Table 25. Global Crude Heparin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Crude Heparin Price by Application (US$/Kg) & (2026-2031)
Table 27. New Sources of Growth in Crude Heparin Application
Table 28. Global Crude Heparin Sales by Company (Tons) & (2020-2025)
Table 29. Global Crude Heparin Sales Share by Company (2020-2025)
Table 30. Global Crude Heparin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Crude Heparin Revenue Share by Company (2020-2025)
Table 32. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2024)
Table 33. Global Market Crude Heparin Average Price by Company (US$/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Crude Heparin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Crude Heparin, Product Type & Application
Table 36. Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 39. North America Crude Heparin Sales Market Share by Company (2020-2025)
Table 40. North America Crude Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Crude Heparin Revenue Market Share by Company (2020-2025)
Table 42. North America Crude Heparin Sales by Type (2020-2025) & (Tons)
Table 43. North America Crude Heparin Sales Market Share by Type (2020-2025)
Table 44. North America Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 45. North America Crude Heparin Sales Market Share by Application (2020-2025)
Table 46. Europe Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 47. Europe Crude Heparin Sales Market Share by Company (2020-2025)
Table 48. Europe Crude Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Crude Heparin Revenue Market Share by Company (2020-2025)
Table 50. Europe Crude Heparin Sales by Type (2020-2025) & (Tons)
Table 51. Europe Crude Heparin Sales Market Share by Type (2020-2025)
Table 52. Europe Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 53. Europe Crude Heparin Sales Market Share by Application (2020-2025)
Table 54. China Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 55. China Crude Heparin Sales Market Share by Company (2020-2025)
Table 56. China Crude Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Crude Heparin Revenue Market Share by Company (2020-2025)
Table 58. China Crude Heparin Sales by Type (2020-2025) & (Tons)
Table 59. China Crude Heparin Sales Market Share by Type (2020-2025)
Table 60. China Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 61. China Crude Heparin Sales Market Share by Application (2020-2025)
Table 62. Japan Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 63. Japan Crude Heparin Sales Market Share by Company (2020-2025)
Table 64. Japan Crude Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Crude Heparin Revenue Market Share by Company (2020-2025)
Table 66. Japan Crude Heparin Sales by Type (2020-2025) & (Tons)
Table 67. Japan Crude Heparin Sales Market Share by Type (2020-2025)
Table 68. Japan Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 69. Japan Crude Heparin Sales Market Share by Application (2020-2025)
Table 70. Bioiberica Company Information
Table 71. Bioiberica Description and Business Overview
Table 72. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Bioiberica Crude Heparin Product
Table 74. Bioiberica Recent Development
Table 75. Shenzhen Hepalink Company Information
Table 76. Shenzhen Hepalink Description and Business Overview
Table 77. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Shenzhen Hepalink Crude Heparin Product
Table 79. Shenzhen Hepalink Recent Development
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Sanofi Crude Heparin Product
Table 84. Sanofi Recent Development
Table 85. Nanjing King-friend Company Information
Table 86. Nanjing King-friend Description and Business Overview
Table 87. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Nanjing King-friend Crude Heparin Product
Table 89. Nanjing King-friend Recent Development
Table 90. Fengrun Biological Technology Company Information
Table 91. Fengrun Biological Technology Description and Business Overview
Table 92. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Fengrun Biological Technology Crude Heparin Product
Table 94. Fengrun Biological Technology Recent Development
Table 95. Aspen Oss Company Information
Table 96. Aspen Oss Description and Business Overview
Table 97. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Aspen Oss Crude Heparin Product
Table 99. Aspen Oss Recent Development
Table 100. Hebei Changshan Biochemical Company Information
Table 101. Hebei Changshan Biochemical Description and Business Overview
Table 102. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Hebei Changshan Biochemical Crude Heparin Product
Table 104. Hebei Changshan Biochemical Recent Development
Table 105. Changzhou Qianhong Company Information
Table 106. Changzhou Qianhong Description and Business Overview
Table 107. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. Changzhou Qianhong Crude Heparin Product
Table 109. Changzhou Qianhong Recent Development
Table 110. Hepac (Darling Ingredients) Company Information
Table 111. Hepac (Darling Ingredients) Description and Business Overview
Table 112. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Hepac (Darling Ingredients) Crude Heparin Product
Table 114. Hepac (Darling Ingredients) Recent Development
Table 115. Huaian MDC Pharmaceutical Company Information
Table 116. Huaian MDC Pharmaceutical Description and Business Overview
Table 117. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 118. Huaian MDC Pharmaceutical Crude Heparin Product
Table 119. Huaian MDC Pharmaceutical Recent Development
Table 120. Yantai Dongcheng Biochemicals Company Information
Table 121. Yantai Dongcheng Biochemicals Description and Business Overview
Table 122. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 123. Yantai Dongcheng Biochemicals Crude Heparin Product
Table 124. Yantai Dongcheng Biochemicals Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Crude Heparin Distributors List
Table 128. Crude Heparin Customers List
Table 129. Crude Heparin Market Trends
Table 130. Crude Heparin Market Drivers
Table 131. Crude Heparin Market Challenges
Table 132. Crude Heparin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Crude Heparin Sales Market Share by Type in 2024 & 2031
Figure 4. Pig Intestine Mucosa Heparin Product Picture
Figure 5. Bovine Heparin and Others Product Picture
Figure 6. Global Crude Heparin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Crude Heparin Sales Market Share by Application in 2024 & 2031
Figure 8. UFH Examples
Figure 9. LMWH Examples
Figure 10. Global Crude Heparin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Crude Heparin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Crude Heparin Sales (Tons) Growth Rate (2020-2031)
Figure 13. Global Crude Heparin Price Trends Growth Rate (2020-2031) & (US$/Kg)
Figure 14. Crude Heparin Report Years Considered
Figure 15. Global Market Crude Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Crude Heparin Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Crude Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Crude Heparin Sales (Tons) Growth Rate (2020-2031)
Figure 19. Europe Crude Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Crude Heparin Sales (Tons) Growth Rate (2020-2031)
Figure 21. China Crude Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Crude Heparin Sales (Tons) Growth Rate (2020-2031)
Figure 23. Japan Crude Heparin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan Crude Heparin Sales (Tons) Growth Rate (2020-2031)
Figure 25. Global Crude Heparin Revenue Share by Type (2020-2025)
Figure 26. Global Crude Heparin Sales Share by Type (2026-2031)
Figure 27. Global Crude Heparin Revenue Share by Type (2026-2031)
Figure 28. Global Crude Heparin Revenue Share by Application (2020-2025)
Figure 29. Global Crude Heparin Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Crude Heparin Sales Share by Application (2026-2031)
Figure 31. Global Crude Heparin Revenue Share by Application (2026-2031)
Figure 32. Global Crude Heparin Sales Share by Company (2024)
Figure 33. Global Crude Heparin Revenue Share by Company (2024)
Figure 34. Global 5 Largest Crude Heparin Players Market Share by Revenue in Crude Heparin: 2020 & 2024
Figure 35. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Crude Heparin
Figure 37. Manufacturing Process Analysis of Crude Heparin
Figure 38. Crude Heparin Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Related Reports
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-17
Pages: 159
USD 5600.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 128
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 124
USD 2900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-07
Pages: 108
USD 4900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-17
Pages: 159
USD 5600.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 128
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 124
USD 2900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research